Aileron Therapeutics Inc has a consensus price target of $10 based on the ratings of 3 analysts. The high is $19 issued by Ladenburg Thalmann on April 18, 2024. The low is $1 issued by HC Wainwright & Co. on June 30, 2022. The 3 most-recent analyst ratings were released by Ladenburg Thalmann, Ladenburg Thalmann, and HC Wainwright & Co. on April 18, 2024, December 1, 2023, and June 30, 2022, respectively. With an average price target of $9.67 between Ladenburg Thalmann, Ladenburg Thalmann, and HC Wainwright & Co., there's an implied 452.38% upside for Aileron Therapeutics Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Aileron Therapeutics (NASDAQ:ALRN) was reported by Ladenburg Thalmann on April 18, 2024. The analyst firm set a price target for $19.00 expecting ALRN to rise to within 12 months (a possible 961.45% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Aileron Therapeutics (NASDAQ:ALRN) was provided by Ladenburg Thalmann, and Aileron Therapeutics maintained their buy rating.
The last upgrade for Aileron Therapeutics Inc happened on December 1, 2023 when Ladenburg Thalmann raised their price target to $9. Ladenburg Thalmann previously had a neutral for Aileron Therapeutics Inc.
The last downgrade for Aileron Therapeutics Inc happened on June 29, 2022 when William Blair changed their price target from N/A to N/A for Aileron Therapeutics Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aileron Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aileron Therapeutics was filed on April 18, 2024 so you should expect the next rating to be made available sometime around April 18, 2025.
While ratings are subjective and will change, the latest Aileron Therapeutics (ALRN) rating was a maintained with a price target of $9.00 to $19.00. The current price Aileron Therapeutics (ALRN) is trading at is $1.79, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.